LLY

1,096.53

-1.32%↓

JNJ

228.19

-2.26%↓

ABBV

216.7

-2.01%↓

UNH

400.27

+0.24%↑

NVS

146.82

-2.48%↓

LLY

1,096.53

-1.32%↓

JNJ

228.19

-2.26%↓

ABBV

216.7

-2.01%↓

UNH

400.27

+0.24%↑

NVS

146.82

-2.48%↓

LLY

1,096.53

-1.32%↓

JNJ

228.19

-2.26%↓

ABBV

216.7

-2.01%↓

UNH

400.27

+0.24%↑

NVS

146.82

-2.48%↓

LLY

1,096.53

-1.32%↓

JNJ

228.19

-2.26%↓

ABBV

216.7

-2.01%↓

UNH

400.27

+0.24%↑

NVS

146.82

-2.48%↓

LLY

1,096.53

-1.32%↓

JNJ

228.19

-2.26%↓

ABBV

216.7

-2.01%↓

UNH

400.27

+0.24%↑

NVS

146.82

-2.48%↓

Search

Thermo Fisher Scientific Inc

Затворен

СекторЗдравеопазване

464.64 0.93

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

464.64

Максимум

467.51

Ключови измерители

By Trading Economics

Приходи

-314M

1.7B

Продажби

-1.2B

11B

P/E

Средно за сектора

26.043

49.712

EPS

5.44

Дивидентна доходност

0.38

Марж на печалбата

15.048

Служители

125,000

EBITDA

-905M

2.3B

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+28.05% upside

Дивиденти

By Acuity

Дивидентна доходност

Средно за сектора

0.38%

2.36%

Следващи печалби

22.07.2026 г.

Следваща дата на дивидент

15.07.2026 г.

Следваща дата на екс-дивидент

14.09.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-19B

176B

Предишно отваряне

463.71

Предишно затваряне

464.64

Настроения в новините

By Acuity

36%

64%

82 / 342 Класиране в Healthcare

Thermo Fisher Scientific Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Относно Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
help-icon Live chat